Sep. 14 at 7:33 PM
Innovation in cancer research continues. 🧬
$BCTX BriaCell Therapeutics Corp. announced a seventh consecutive positive DSMB recommendation for its pivotal Phase 3 Bria-ABC study of Bria-IMT™ plus an immune checkpoint inhibitor.
The company continues advancing its immunotherapy program for metastatic breast cancer.
NEWS: https://bit.ly/46Ho2b3
#BCTX #CancerResearch #Immunotherapy